Background: Health insurance is vital for healthcare financing and aligns with the 2030 Sustainable Development Goal agenda. Women of reproductive age face unique barriers to affordable care due to higher health risks and caregiving roles. This study aims to estimate the proportion of women with health insurance coverage (HIC) and its associated factors. Methods: We used data from the latest round of the Bangladesh Demographic and Health Survey (BDHS) of 2022. The number of women considered for analysis was 19987. Unadjusted odds ratio with their 95% confidence interval (CI) were reported. Results: The median (IQR) age of the women in the study was 32.0 (25.0-39.0) years. Only 0.3% of women reported having HIC. The odds of HIC increased significantly with having account with bank or other financial institution (UOR: 2.27; 95% CI: 1.36-3.79), both woman or their husbands having post-secondary education, belonging to richest family (UOR: 3.32; 95% CI: 1.45-7.60), and having adequate media exposure (UOR: 2.78; 95% CI: 1.41-5.47). Conclusions: The study highlights the need for higher education among both sexes and targeted strategies to reduce wealth-based disparities and use mass media to promote the uptake of HIC.

The authors have declared no competing interest.

None received

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

We utilized secondary data obtained from the DHS website (https://dhsprogram.com/) on request, where all identifiable information has been removed to ensure anonymity. As we conducted analysis on secondary data, no ethical clearance is required.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes